FDA Orange Book · active-ingredient family
Bupropion hydrochloride
Bupropion hydrochloride is approved as 5 brand and 62 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:FORFIVO XL · NDA 022497
5
Brand (NDA)
62
Generics (ANDA)
1
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet, tablet, extended release
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| FORFIVO XLRLD | TWI PHARMS | NDA 022497 | — | Nov 10, 2011 | |
| WELLBUTRIN XLRLD×2 | BAUSCH | NDA 021515 | AB3 | Aug 28, 2003 | |
| ZYBANRLD×2 | GLAXOSMITHKLINE | NDA 020711 | — | May 14, 1997 | |
| WELLBUTRIN SRRLD×4 | GLAXOSMITHKLINE | NDA 020358 | AB1 | Oct 04, 1996 | |
| WELLBUTRINRLD×3 | GLAXOSMITHKLINE | NDA 018644 | — | Dec 30, 1985 |
Generic (ANDA) products (62)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| BUPROPION HYDROCHLORIDE×3 | YICHANG HUMANWELL | ANDA 220529 | AB1 | May 04, 2026 | |
| BUPROPION HYDROCHLORIDE×2 | ANNORA PHARMA | ANDA 217898 | AB3 | Oct 01, 2025 | |
| BUPROPION HYDROCHLORIDE×3 | IPCA LABS LTD | ANDA 207874 | AB1 | May 02, 2025 | |
| BUPROPION HYDROCHLORIDE×3 | GRANULES | ANDA 218385 | AB1 | Oct 17, 2024 | |
| BUPROPION HYDROCHLORIDE×3 | ANNORA PHARMA | ANDA 216800 | AB1 | May 31, 2023 | |
| BUPROPION HYDROCHLORIDE | YICHANG HUMANWELL | ANDA 216766 | AB2 | Jan 09, 2023 | |
| BUPROPION HYDROCHLORIDE×2 | GRANULES | ANDA 215568 | AB3 | Feb 02, 2022 | |
| BUPROPION HYDROCHLORIDE | SUN PHARM | ANDA 203650 | — | Dec 31, 2020 | |
| BUPROPION HYDROCHLORIDE | SUN PHARM | ANDA 200216 | — | Nov 30, 2020 | |
| BUPROPION HYDROCHLORIDE×2 | ZHEJIANG JUTAI PHARM | ANDA 211200 | AB3 | Apr 29, 2020 | |
| BUPROPION HYDROCHLORIDE×2 | MICRO LABS | ANDA 207403 | AB | Apr 17, 2020 | |
| BUPROPION HYDROCHLORIDE×2 | CADILA PHARMS LTD | ANDA 208606 | AB | Jan 16, 2020 | |
| BUPROPION HYDROCHLORIDE×2 | GRAVITI PHARMS | ANDA 211020 | AB3 | Jan 28, 2019 | |
| BUPROPION HYDROCHLORIDE×2 | ACCORD HLTHCARE | ANDA 210497 | AB3 | Oct 31, 2018 | |
| BUPROPION HYDROCHLORIDE×3 | YICHANG HUMANWELL | ANDA 211347 | AB1 | Oct 16, 2018 | |
| BUPROPION HYDROCHLORIDE×2 | ZYDUS PHARMS | ANDA 201567 | AB3 | Jul 23, 2018 | |
| BUPROPION HYDROCHLORIDE×2 | YICHANG HUMANWELL | ANDA 210015 | AB3 | Jun 14, 2018 | |
| BUPROPION HYDROCHLORIDE×2 | ALEMBIC | ANDA 203013 | AB | Jun 08, 2018 | |
| BUPROPION HYDROCHLORIDE×2 | TWI PHARMS | ANDA 210081 | — | Nov 03, 2017 | |
| BUPROPION HYDROCHLORIDE×2 | INVAGEN PHARMS | ANDA 207389 | — | Sep 18, 2017 | |
| BUPROPION HYDROCHLORIDE×2 | SINOTHERAPEUTICS INC | ANDA 208652 | AB3 | Aug 21, 2017 | |
| BUPROPION HYDROCHLORIDE×2 | ANBISON LAB | ANDA 207224 | AB3 | Jun 30, 2017 | |
| BUPROPION HYDROCHLORIDE×2 | JUBILANT GENERICS | ANDA 207459 | — | Jun 30, 2017 | |
| BUPROPION HYDROCHLORIDE×2 | SCIEGEN PHARMS | ANDA 207479 | AB3 | Apr 12, 2017 | |
| BUPROPION HYDROCHLORIDE×2 | LUPIN | ANDA 090693 | AB3 | Apr 06, 2017 | |
| BUPROPION HYDROCHLORIDE×2 | INVAGEN PHARMS | ANDA 206556 | — | Aug 26, 2016 | |
| BUPROPION HYDROCHLORIDE×2 | HERITAGE PHARMA | ANDA 206975 | AB | Aug 19, 2016 | |
| BUPROPION HYDROCHLORIDE | SCIEGEN PHARMS | ANDA 206122 | AB2 | Aug 17, 2016 | |
| BUPROPION HYDROCHLORIDE×3 | SCIEGEN PHARMS | ANDA 205794 | AB1 | Mar 01, 2016 | |
| BUPROPION HYDROCHLORIDE×3 | INVAGEN PHARMS | ANDA 206674 | — | Feb 09, 2016 | |
| BUPROPION HYDROCHLORIDE×3 | PRINSTON INC | ANDA 202304 | AB1 | May 26, 2015 | |
| BUPROPION HYDROCHLORIDE | SUN PHARM | ANDA 200695 | — | Dec 18, 2014 | |
| BUPROPION HYDROCHLORIDE×3 | TORRENT | ANDA 203969 | — | Oct 31, 2014 | |
| BUPROPION HYDROCHLORIDE×3 | JUBILANT GENERICS | ANDA 202774 | — | Oct 11, 2013 | |
| BUPROPION HYDROCHLORIDE | JUBILANT GENERICS | ANDA 202775 | — | Oct 11, 2013 | |
| BUPROPION HYDROCHLORIDE×2 | WOCKHARDT LTD | ANDA 202189 | AB3 | Nov 21, 2012 | |
| BUPROPION HYDROCHLORIDE×3 | WOCKHARDT LTD | ANDA 201331 | — | Aug 30, 2012 | |
| BUPROPION HYDROCHLORIDE×3 | PH HEALTH | ANDA 091459 | — | Jun 09, 2011 | |
| BUPROPION HYDROCHLORIDE | PH HEALTH | ANDA 091520 | — | Jun 09, 2011 | |
| BUPROPION HYDROCHLORIDE×3 | WATSON LABS INC | ANDA 077455 | — | Jul 19, 2010 | |
| BUPROPION HYDROCHLORIDE×2 | AUROBINDO PHARMA USA | ANDA 090942 | — | Jul 14, 2010 | |
| BUPROPION HYDROCHLORIDE | RISING | ANDA 090941 | — | May 03, 2010 | |
| BUPROPION HYDROCHLORIDE×3 | AUROBINDO PHARMA USA | ANDA 090325 | AB1 | Apr 08, 2010 | |
| BUPROPION HYDROCHLORIDE×3 | SUN PHARM | ANDA 078866 | — | Apr 06, 2010 | |
| BUPROPION HYDROCHLORIDE×3 | ACTAVIS LABS FL INC | ANDA 079095 | AB1 | Mar 24, 2009 | |
| BUPROPION HYDROCHLORIDE | ACTAVIS LABS FL INC | ANDA 079094 | AB2 | Mar 24, 2009 | |
| BUPROPION HYDROCHLORIDE×2 | ACTAVIS LABS FL INC | ANDA 077715 | AB3 | Nov 26, 2008 | |
| BUPROPION HYDROCHLORIDE×2 | IMPAX LABS | ANDA 077415 | — | Nov 26, 2008 | |
| BUPROPION HYDROCHLORIDE×2 | WATSON LABS INC | ANDA 077285 | AB3 | Nov 26, 2008 | |
| BUPROPION HYDROCHLORIDE | SANDOZ | ANDA 077475 | AB2 | Mar 12, 2008 | |
| BUPROPION HYDROCHLORIDE×2 | PH HEALTH | ANDA 077284 | — | Dec 14, 2006 | |
| BUPROPION HYDROCHLORIDE×2 | APOTEX | ANDA 076143 | AB | Jan 17, 2006 | |
| BUPROPION HYDROCHLORIDE | CHARTWELL RX | ANDA 076834 | — | Jul 14, 2005 | |
| BUPROPION HYDROCHLORIDE×2 | SANDOZ | ANDA 076845 | — | Jul 14, 2005 | |
| BUPROPION HYDROCHLORIDE | IMPAX LABS | ANDA 076711 | — | Dec 03, 2004 | |
| BUPROPION HYDROCHLORIDE | IMPAX LABS | ANDA 075914 | AB2 | May 27, 2004 | |
| BUPROPION HYDROCHLORIDE×2 | IMPAX LABS | ANDA 075913 | AB1 | Jan 28, 2004 | |
| BUPROPION HYDROCHLORIDE×3 | EPIC PHARMA LLC | ANDA 075932 | AB1 | Nov 25, 2003 | |
| BUPROPION HYDROCHLORIDE×2 | INVATECH | ANDA 075613 | — | Oct 10, 2000 | |
| BUPROPION HYDROCHLORIDE×2 | AUROBINDO PHARMA USA | ANDA 075491 | AB | Apr 17, 2000 | |
| BUPROPION HYDROCHLORIDE×2 | SENORES PHARMS | ANDA 075584 | AB | Feb 07, 2000 | |
| BUPROPION HYDROCHLORIDE×2 | HERITAGE PHARMA | ANDA 075310 | — | Nov 29, 1999 |
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7674479 | Aug 23, 2028 | in 2 yr 3 mo | Product |
Bupropion hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

